SCOTUS Must Not Look Away as Pregnant Patients Suffer
The Supreme Court must maintain pregnant people’s right to receive emergency medical care—including abortion.
A New Era of Psychedelic Medicine in Australia
Australia implements a new framework for regulating the medicinal use of psychedelic substances such as MDMA and psilocybin.
It Is High Time the U.K. Changes Psychedelics Laws
The government should lower regulatory hurdles impeding psilocybin assisted psychotherapy research.
ESG and “Stakeholderism”
Lisa Fairfax explains how stakeholder concerns play a role in FINRA regulation, corporate governance, and ESG.
Reforming Donor-Advised Funds
Practitioners and scholars navigate the evolving challenges posed by donor-advised funds.
Week in Review
The U.S. Supreme Court allows a state to temporarily ban gender-affirming care, the EEOC requires employers to provide reasonable accommodations for abortions, and more…
Why We Need To Talk About Psychedelic Dispensaries
Dispensaries could fill the regulatory void for psychedelics and promote public health.
Are Psychedelics Safe Enough for Recreational Use?
Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.
A Roadmap to Reimbursement for Psychedelics
Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.
Global Perspectives on Psychedelics Regulation
Experts discuss the benefits and drawbacks of existing regulatory frameworks for psychedelics.
Branching Regulatory Paths and Dead Ends in Psychedelics
The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.
Protecting Against Sexual Violence Linked to Deepfake Technology
Scholars and researchers navigate the evolving challenges posed by deepfake technology.